|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2010-11-4
|
|
pubmed:abstractText |
Mucosa-associated bacteria are increased in inflammatory bowel disease (IBD), which suggests the possibility of an increased source of digestible endogenous mucus substrate. We hypothesized that mucolytic bacteria are increased in IBD, providing increased substrate to sustain nonmucolytic mucosa-associated bacteria.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1572-0241
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
105
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2420-8
|
|
pubmed:meshHeading |
pubmed-meshheading:20648002-Adult,
pubmed-meshheading:20648002-Aged,
pubmed-meshheading:20648002-Aged, 80 and over,
pubmed-meshheading:20648002-Colon,
pubmed-meshheading:20648002-Female,
pubmed-meshheading:20648002-Humans,
pubmed-meshheading:20648002-Inflammatory Bowel Diseases,
pubmed-meshheading:20648002-Intestinal Mucosa,
pubmed-meshheading:20648002-Male,
pubmed-meshheading:20648002-Middle Aged,
pubmed-meshheading:20648002-Mucins,
pubmed-meshheading:20648002-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:20648002-Ruminococcus
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria.
|
|
pubmed:affiliation |
Mater Medical Research Institute and Department of Medicine, University of Queensland, Mater Health Services, South Brisbane, Queensland, Australia.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
